P01 CA094237-08/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	5
2010	3
2011	3
2024	0

1

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety.

Hoyos V, Savoldo B, Quintarelli C, Mahendravada A, Zhang M, Vera J, Heslop HE, Rooney CM, Brenner MK, Dotti G. Hoyos V, et al. Leukemia. 2010 Jun;24(6):1160-70. doi: 10.1038/leu.2010.75. Epub 2010 Apr 29. Leukemia. 2010. PMID: 20428207 Free PMC article.

2

Adoptive T cell therapy of cancer.

Schumacher TN, Restifo NP. Schumacher TN, et al. Curr Opin Immunol. 2009 Apr;21(2):187-9. doi: 10.1016/j.coi.2009.03.006. Epub 2009 Mar 26. Curr Opin Immunol. 2009. PMID: 19328668 Free PMC article. No abstract available.

3

How I treat EBV lymphoproliferation.

Heslop HE. Heslop HE. Blood. 2009 Nov 5;114(19):4002-8. doi: 10.1182/blood-2009-07-143545. Epub 2009 Sep 1. Blood. 2009. PMID: 19724053 Free PMC article. Review.

4

Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.

Shaffer DR, Rooney CM, Gottschalk S. Shaffer DR, et al. Immunotherapy. 2010 Sep;2(5):663-71. doi: 10.2217/imt.10.43. Immunotherapy. 2010. PMID: 20874650 Free PMC article. Review.

5

Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics.

Louis CU, Brenner MK. Louis CU, et al. Curr Pharm Des. 2009;15(4):424-9. doi: 10.2174/138161209787315765. Curr Pharm Des. 2009. PMID: 19199969 Free PMC article. Review.

6

Adoptive T cell therapy of cancer.

Brenner MK, Heslop HE. Brenner MK, et al. Curr Opin Immunol. 2010 Apr;22(2):251-7. doi: 10.1016/j.coi.2010.01.020. Epub 2010 Feb 17. Curr Opin Immunol. 2010. PMID: 20171074 Free PMC article. Review.

7

Getting personal with melanoma.

Heslop H. Heslop H. Clin Cancer Res. 2011 Jul 1;17(13):4189-91. doi: 10.1158/1078-0432.CCR-11-0841. Epub 2011 Jun 28. Clin Cancer Res. 2011. PMID: 21712453 Free PMC article.

8

Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.

Vera JF, Hoyos V, Savoldo B, Quintarelli C, Giordano Attianese GM, Leen AM, Liu H, Foster AE, Heslop HE, Rooney CM, Brenner MK, Dotti G. Vera JF, et al. Mol Ther. 2009 May;17(5):880-8. doi: 10.1038/mt.2009.34. Epub 2009 Mar 3. Mol Ther. 2009. PMID: 19259067 Free PMC article.

9

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).

De Angelis B, Dotti G, Quintarelli C, Huye LE, Zhang L, Zhang M, Pane F, Heslop HE, Brenner MK, Rooney CM, Savoldo B. De Angelis B, et al. Blood. 2009 Nov 26;114(23):4784-91. doi: 10.1182/blood-2009-07-230482. Epub 2009 Sep 16. Blood. 2009. PMID: 19759356 Free PMC article.

10

Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination.

Huye LE, Nakazawa Y, Patel MP, Yvon E, Sun J, Savoldo B, Wilson MH, Dotti G, Rooney CM. Huye LE, et al. Mol Ther. 2011 Dec;19(12):2239-48. doi: 10.1038/mt.2011.179. Epub 2011 Aug 30. Mol Ther. 2011. PMID: 21878902 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year